Aujeszky’s disease is a viral infection of pigs caused by pseudorabies virus (PRV), a member of the alphaherpesvirus family. Despite its alternative name, it has nothing to do with human rabies. The disease produces a range of problems in swine, from fatal brain inflammation in piglets to breathing difficulties in older pigs and reproductive failure in breeding animals, and it kills nearly every non-pig mammal it infects. Countries have spent decades and billions of dollars trying to stamp it out, and while many have succeeded, the virus persists stubbornly in wild boar populations and has recently thrown a curveball with variant strains that punch through existing vaccines.
What the Virus Does to Pigs
Pigs are the only natural reservoir for pseudorabies virus, meaning they are the only species in which the virus can maintain itself long-term. What happens to an infected pig depends heavily on age. Newborn piglets develop severe neurological disease, with trembling, seizures, and high mortality rates. Growing and adult pigs tend to get respiratory illness instead. Breeding sows and boars suffer reproductive problems, including stillbirths and infertility.1Journal of the Hellenic Veterinary Medical Society. Aujeszky’s Disease (Pseudorabies). An old threat in current pig industry? Part I. Pathogenetic information and implications This age-dependent spectrum is one reason the disease is so economically damaging: it simultaneously kills the youngest animals, slows the growth of the middle ones, and reduces fertility in the breeding herd.
Older pigs that survive infection typically clear the acute illness but do not clear the virus. Like other alphaherpesviruses, PRV establishes latency in nerve cells, particularly in the ganglia of the head and neck, and at lower levels in tonsil tissue.2PubMed Central. Recent developments in latency and recombination of Aujeszky’s disease (pseudorabies) virus Latently infected pigs look perfectly healthy but carry the virus for life. If they become stressed or immunosuppressed, the virus can reactivate and start shedding again, turning apparently clean animals into silent spreaders.
How the Virus Spreads
Transmission happens primarily through the respiratory route. Infected pigs shed virus in nasal secretions, and close nose-to-nose contact in a barn or wallowing area is the classic pathway. Virus can also be found in tonsils and occasionally in genital secretions.3PubMed. Mechanisms of transmission of Aujeszky’s disease virus originating from feral swine in the USA In wild or feral pig populations, cannibalism of animals that die from acute infection is another documented transmission route.4PubMed. Mechanisms of transmission of Aujeszky’s disease virus originating from feral swine in the USA
The virus can persist in the environment for meaningful periods under favorable conditions. At cool temperatures and a near-neutral pH range of roughly 6 to 8, inactivation is slow, losing infectivity at a rate of only about 0.04 log units per day at refrigerator temperatures. At body temperature, the rate jumps to around 0.6 log units per day.5PubMed. Influence of environmental factors upon the survival of Aujeszky’s disease virus Humidity helps the virus survive longer, while dryness and direct sunlight accelerate its destruction. Strong acids, strong alkalis, and standard disinfectants all kill it effectively at adequate concentrations.6PubMed Central. Effects of physical and chemical factors on pseudorabies virus activity in vitro One quirk: repeated freeze-thaw cycles barely dent the virus’s infectivity, which matters for meat and offal that might be frozen, thawed, and refrozen during transport or storage.7PubMed Central. Effects of physical and chemical factors on pseudorabies virus activity in vitro
The “Mad Itch” and Why Other Animals Die
Pigs can survive infection, but virtually every other mammal that contracts the virus dies. Cattle, dogs, cats, sheep, goats, rats, and many wild species develop a rapid, fatal neurological disease. The hallmark symptom in these non-pig hosts is an agonizing itch, documented since the nineteenth century, that drives animals to scratch and bite themselves raw. This “mad itch” is a severe neuropathy caused by the virus attacking peripheral nerves. Strangely, pigs never develop this symptom, even though they carry the same virus.8PubMed Central. The Neuropathic Itch Caused by Pseudorabies Virus
The reason for this discrepancy is still being studied. In pigs, the immune system appears to contain the virus before it causes the kind of uncontrolled nerve damage seen in other species. The virus has evolved alongside pigs for millennia, and in that coevolution, a rough truce developed: the virus gets to persist quietly, and the pig gets to survive. Other mammals have no such evolutionary bargain. Once PRV gets into a non-pig host’s nervous system, it spreads explosively, and death typically follows within days.
Dogs and Hunting
One group of non-pig animals at particular risk is hunting dogs. Cases pop up repeatedly in countries where hunters use dogs to track or bay wild boar. The exposure pathway is straightforward: dogs eat raw meat or offal from a wild boar carrying the virus, and the infection takes hold. In Poland, a hunting dog died after contact with wild boar offal in what was reported as the country’s first documented case.9Journal of Veterinary Research. Wild boar offal as a probable source of Aujeszky’s disease virus for hunting dogs in Poland In Sicily, two hunting dogs died after eating raw wild boar meat.10PubMed Central. Aujeszky’s disease in hunting dogs after the ingestion of wild boar raw meat in Sicily (Italy): clinical, diagnostic and phylogenetic features In the United States, cases were detected in Alabama and Arkansas, with one dog falling ill after a competitive wild hog rodeo and others after hunting feral swine and eating the remains.11PubMed Central. Pseudorabies detected in hunting dogs in Alabama and Arkansas after close contact with feral swine (Sus scrofa)
The disease in dogs manifests as severe neurological collapse, including intense scratching of the face and head, disorientation, drooling, and rapid progression to death. There is no effective treatment. Once clinical signs appear, the outcome is invariably fatal.12Journal of Veterinary Research. Wild boar offal as a probable source of Aujeszky’s disease virus for hunting dogs in Poland The practical takeaway for anyone who hunts with dogs around wild boar: never allow dogs to eat raw pork of any kind, including organs, scraps, or carcasses left in the field. Cooking destroys the virus, but any raw tissue from an infected boar is potentially lethal.
Wild Boar as a Persistent Reservoir
Eradicating Aujeszky’s disease from domestic pig herds is hard enough. Eradicating it from wild boar is essentially impossible with current tools. Wild boar populations across Europe and in parts of the Americas carry the virus at significant rates, and these populations serve as a reservoir that constantly threatens to reinfect domestic herds. In Spain, the virus is considered enzootic in Iberian wild boar, creating ongoing headaches for the country’s eradication program in outdoor pig farms.13PubMed. Dynamics of Aujeszky’s disease virus infection in wild boar in enzootic scenarios
Poland presents an instructive case. The country has achieved official Aujeszky’s disease-free status in its domestic herds, but serological surveys of wild boar show that the virus is still circulating in the wild population. That creates a dual problem: the risk of spillover back into pig farms, and the continuing threat to other domestic and wild mammals that encounter infected boar.14PubMed Central. Serological survey and associated risk factors of Aujeszky’s disease virus in wild boar from south and central Poland Countries that have declared freedom from the disease still need ongoing surveillance at the wildlife-livestock interface, because a single infected boar wandering onto an outdoor pig farm could restart the cycle.
How Countries Eliminated the Disease
The eradication of Aujeszky’s disease from commercial pig herds ranks as one of the larger veterinary achievements of the past few decades. The United States launched its official program in 1989, organizing it as a five-stage progression. Each state moved from an organizational phase through increasingly strict testing and quarantine requirements, eventually reaching “free” status. By mid-1999, 32 states had achieved free status and another 8 were in the final pre-free stage. Over 20,000 herds had been released from quarantine by that point, and the program targeted having all remaining infected herds cleared by 2000.15Veterinary Research. The eradication of Aujeszky’s disease in the United States
Germany followed a similar arc. After reunification brought together two countries with very different pig industries and disease burdens, a national program was established. In western Germany, outbreaks had been running at around 2,000 cases per year in the late 1980s. After steady effort through the 1990s, cases fell to zero in 2001, and Germany was declared officially free by the European Commission.16PubMed. Eradication of Aujeszky’s disease in Germany Most of western Europe followed suit over the same period. The common ingredients in every successful program were mandatory vaccination, systematic blood testing, quarantine and removal of infected animals, and strict biosecurity upgrades at farm level.
The DIVA Vaccination Breakthrough
A pivotal tool in these eradication campaigns was a type of vaccine that allowed veterinarians to tell the difference between a vaccinated pig and a genuinely infected one. This “marker” approach, often called DIVA (differentiating infected from vaccinated animals), was born from work on PRV in the mid-1980s. Researchers discovered that some live-attenuated vaccine strains were missing the gene for a major viral surface protein called glycoprotein E. Pigs vaccinated with these gE-deleted strains developed immunity but never produced antibodies against gE. Pigs that caught the real virus, on the other hand, always made gE antibodies. A blood test for gE antibodies could therefore separate the two groups cleanly.17PubMed Central. Aujeszky’s Disease and the Development of the Marker/DIVA Vaccination Concept
This was a genuinely important advance, not just for Aujeszky’s disease but for veterinary vaccinology broadly. Before DIVA, eradication programs faced a dilemma: vaccinate and lose the ability to detect infected herds through blood testing, or don’t vaccinate and accept higher disease levels. The gE-deleted vaccines resolved that tension. Companion DIVA ELISA tests using recombinant gE protein continue to be refined for improved sensitivity and specificity.18PubMed. Development of a DIVA ELISA for diagnosis of Aujeszky’s disease using recombinant gE fused to thioredoxin as antigen The DIVA concept has since been adapted for other livestock diseases, making PRV the virus that pioneered marker vaccination for the whole field.
Diagnosis in Practice
When Aujeszky’s disease is suspected, virus isolation has traditionally been the gold standard for confirming infection. The problem with virus isolation is that it is slow, labor-intensive, and requires specialized labs. Real-time PCR testing offers a faster and increasingly validated alternative. Commercial kits have been tested for their ability to match virus isolation results and have received full diagnostic validation for field use.19PubMed. Validation of a commercial real-time PCR kit for specific and sensitive detection of Pseudorabies Serological testing for antibodies, particularly the gE-based ELISA mentioned above, remains the workhorse for surveillance in herds and in wildlife surveys.
Variant Strains and the Situation in China
Just when it seemed like the Aujeszky’s disease playbook was well established, the virus changed the game. In 2011, outbreaks began appearing in Chinese pig herds that had been vaccinated with the widely used Bartha K61 vaccine strain, a gE-deleted live vaccine that had been the backbone of control programs worldwide. A variant PRV strain was breaking through vaccine-induced immunity and spreading through large commercial operations.20PubMed Central. A Review of Pseudorabies Virus Variants: Genomics, Vaccination, Transmission, and Zoonotic Potential
These variant strains appear to have accumulated enough genetic changes to partially evade the immune response triggered by classical vaccines. The situation has driven a wave of research into updated vaccines, including new live-attenuated strains derived from the variant viruses themselves and inactivated formulations. The Chinese experience is a reminder that PRV, like any herpesvirus, continues to evolve, and a vaccine that worked for three decades is not guaranteed to work forever.
How the Virus Dodges Immunity
Part of what makes PRV such a persistent problem is its arsenal of tricks for evading the host’s immune defenses. The virus actively suppresses the innate immune response, the first-line alarm system that kicks in before targeted antibodies are produced.21PubMed Central. Progress on innate immune evasion and live attenuated vaccine of pseudorabies virus One well-characterized mechanism involves a viral enzyme called UL13, which directly interferes with the signaling pathway that would normally trigger production of interferon-beta, a key antiviral molecule. UL13 does this by chemically modifying a host protein called IRF3, preventing it from binding to the DNA sequences that would switch on interferon genes. The result is a blunted antiviral response during early infection, giving the virus a larger window to replicate and spread to nerve cells before the immune system can contain it.22PubMed Central. PRV UL13 inhibits cGAS-STING-mediated IFN-β production by phosphorylating IRF3
UL13 is just one of several viral proteins involved in immune evasion. PRV encodes over 70 known protein-coding genes across a genome of about 143,000 nucleotide pairs, comparable in complexity to other alphaherpesviruses.23PubMed Central. Complete, annotated sequence of the pseudorabies virus genome Researchers have identified multiple other gene products that interfere with different arms of the immune response, and the interplay between them helps explain both why pigs can be reinfected after immunity wanes and why vaccine-induced protection can sometimes be incomplete.
PRV as a Vaccine Platform for Other Diseases
An unexpected second act for pseudorabies virus has been its use as a vector for delivering vaccines against entirely different pig diseases. The idea is elegantly simple: since you already need to vaccinate pigs against PRV, why not engineer the vaccine strain to also carry a gene from another pathogen? When the pig’s immune system responds to the modified vaccine, it builds immunity against both PRV and the hitchhiking antigen.
This concept has been tested with several important swine pathogens. One group constructed a PRV mutant lacking both the gD and gE genes, making it unable to spread from pig to pig, and inserted a gene from classical swine fever virus. Vaccinated pigs were protected against both diseases.24PubMed. Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky’s disease and classical swine fever Another team built a recombinant PRV carrying a key protein from porcine parvovirus, a virus that causes reproductive failure in sows. The resulting bivalent vaccine protected piglets against PRV and primed breeding animals against parvovirus.25PubMed Central. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine These vector vaccines are appealing because they reduce the number of injections pigs need and cut costs for farmers who are already vaccinating against PRV anyway.
Can Humans Get Aujeszky’s Disease?
For most of the virus’s known history, the answer was a confident no. PRV was considered a purely animal disease, with humans regarded as resistant. That confidence has weakened somewhat in recent years, particularly after reports from China of encephalitis cases in people who had close contact with pigs or raw pork, where PRV was detected in clinical samples.26PubMed Central. A Review of Pseudorabies Virus Variants: Genomics, Vaccination, Transmission, and Zoonotic Potential Whether the emerging variant strains have acquired an enhanced ability to infect humans, or whether human cases were simply underrecognized before modern diagnostics, remains unclear. The number of suspected human cases is still very small, and the overall risk to people in countries with controlled or eradicated domestic pig populations appears to be minimal. Still, the possibility has shifted PRV from a “definitely not zoonotic” category to a “probably not, but being watched” one.
Living with the Virus in Wildlife
The practical reality for most countries that have eliminated Aujeszky’s disease from their pig farms is that the virus is not actually gone. It circulates in wild boar, and as boar populations expand across Europe and North America, the wildlife reservoir grows with them. Outdoor and organic pig operations, where animals may share fence lines or pastures with wild boar, face higher reintroduction risk than fully indoor farms. Hunting dogs remain at risk wherever wild boar are hunted. And emerging variants, especially those arising in regions with dense, intensively farmed pig populations, add a layer of unpredictability that decades of successful eradication programs did not fully prepare the industry for.
Surveillance at the interface between wild boar and domestic pigs remains the main line of defense. In countries like Spain, where outdoor pig farming is culturally and economically important, understanding the dynamics of infection in wild boar is essential for protecting domestic herds.27PubMed. Dynamics of Aujeszky’s disease virus infection in wild boar in enzootic scenarios In countries like Poland, where domestic freedom has been achieved but wild boar remain positive, the surveillance has a slightly different flavor: less about active firefighting and more about early warning, detecting any sign that the virus is creeping back toward the farm gate.28PubMed Central. Serological survey and associated risk factors of Aujeszky’s disease virus in wild boar from south and central Poland In both cases, the virus’s persistence in wildlife ensures that Aujeszky’s disease, for all the progress made against it, is not a story with a tidy ending.